Rankings
▼
Calendar
TRDA FY 2024 Earnings — Entrada Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TRDA
Entrada Therapeutics, Inc.
$502M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$211M
+63.4% YoY
Gross Profit
$211M
100.0% margin
Operating Income
$47M
22.3% margin
Net Income
$66M
31.1% margin
EPS (Diluted)
$1.68
Cash Flow
Operating Cash Flow
-$42M
Free Cash Flow
-$45M
Stock-Based Comp.
$18M
Balance Sheet
Total Assets
$526M
Total Liabilities
$98M
Stockholders' Equity
$429M
Cash & Equivalents
$101M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$211M
$129M
+63.4%
Gross Profit
$211M
$129M
+63.4%
Operating Income
$47M
-$3M
+1586.7%
Net Income
$66M
-$7M
+1081.7%
← Q4 2023
All Quarters
Q1 2024 →